INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $30,000 | -26.8% | 31,174 | +42.3% | 0.00% | -50.0% |
| Q1 2019 | $41,000 | -83.0% | 21,910 | -87.9% | 0.00% | -83.3% |
| Q3 2017 | $241,000 | +69.7% | 181,220 | +99.8% | 0.01% | +50.0% |
| Q2 2017 | $142,000 | +373.3% | 90,720 | +367.6% | 0.01% | -20.0% |
| Q3 2016 | $30,000 | -85.7% | 19,400 | -87.8% | 0.01% | 0.0% |
| Q2 2016 | $210,000 | -89.4% | 158,507 | -12.4% | 0.01% | -84.8% |
| Q2 2015 | $1,981,000 | +607.5% | 180,925 | +766.6% | 0.07% | +407.7% |
| Q3 2014 | $280,000 | -53.7% | 20,877 | -52.4% | 0.01% | -59.4% |
| Q4 2013 | $605,000 | -91.2% | 43,866 | -89.6% | 0.03% | -85.7% |
| Q2 2013 | $6,849,000 | – | 423,079 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |